Delivery Order SPE2DB22D1202-SPE2DB24FUNQ9
Award Date
1/26/24
Potential Completion Date
1/29/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $9,799.79 order is for the delivery of ACTIVASE 50 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, with a potential value of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,658.46, requires the delivery of ACTIVASE 100 MG VIALS medical supplies by March 1, 2024. The contract is not set aside for any special business categories. Amerisourcebergen Drug Corp is the prime contractor on this order, which is issued under a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a potential value of $10,990.82 and a completion date of February 2, 2024. This delivery order is placed under Amerisourcebergen's indefinite delivery contract (IDC) with DLA, which has a potential...
This firm fixed price delivery order, valued at $11,458.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the delivery of ACTIVASE 50 MG VIALS to a location in Conshohocken, Pennsylvania, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is not associated with any set-aside designation. The company holds an indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $14,034.50, is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price type with a completion date of February 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, for the supply of ACTIVASE 50 MG VIALS. The order has a potential value of $13,624.90 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. In addition to this delivery order, Amerisourcebergen Drug Corp holds an...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $35,574.74 to supply 4,563,603,224 units of ACTIVASE 100 MG VIALS. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4,563,709,872 units of the pharmaceutical product ACTIVASE 100 MG VIALS. The award has a potential value of $10,697.86 and a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to supply pharmaceuticals and medical supplies, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $58,802.81 firm fixed-price contract is for the supply of 4565108834 ACTIVASE 100 MG VIALS. Amerisourcebergen, a leading pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,323.36 and a period of performance through May 6, 2024. The award is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00...